Pericarditis clinical trials at UCSD
1 research study open to eligible people
open to eligible people ages 7 years and up
The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.
La Jolla, California and other locations
Our lead scientists for Pericarditis research studies include Ajit Raisinghani, MD.